Introduction {#s1}
============

Mycobacteria use a set of specialized secretion systems called ESX to transport proteins across their complex, diderm cell walls ([@bib20]). Originally described as virulence factors in *Mycobacteria tuberculosis* ([@bib21]; [@bib25]; [@bib34]; [@bib54]), orthologs of ESX have since been discovered in most Gram-positive bacteria ([@bib9]), and are more generally referred to as Type VII secretion systems ([@bib6]). In mycobacteria there are five paralogous ESX operons (ESX 1--5) each of which encodes an inner membrane translocon complex consisting of three conserved Ecc proteins: EccB, EccC, and EccD. A fourth protein, EccE is conserved in all ESX operons except the ancestral ESX-4 operon and is also considered a part of the ESX translocon complex as it copurifies with EccB, EccC, and EccD ([@bib24]). All Type VII secretion systems translocate proteins in the WXG100-superfamily, which share a common two-helix hairpin structure and are found as homo- or heterodimers ([@bib41]) and are mutually dependent for secretion with other substrates ([@bib16]). In contrast to the general secretory apparatus (Sec), ESX substrates have been shown to be secreted in their folded, dimeric state ([@bib56]).

Structural and functional information has been reported for truncated and isolated, soluble domains of the ESX translocon complexes and their homologs ([@bib31]; [@bib30]; [@bib44]; [@bib47]; [@bib55]; [@bib63]; [@bib62]; [@bib61]; [@bib64]; [@bib67]). A low resolution, negative stain electron microscopy structure of ESX-5 shows a translocon complex assembled into a hexamer ([@bib5]). Structures of other proteins encoded in ESX operons including secreted substrates ([@bib26]), substrate chaperons ([@bib12]), and the protease MycP ([@bib53]) have been solved. Despite revealing important functional information about ESX, structures of overexpressed and isolated proteins are insufficient to understand the regulated secretion of fully folded substrates. We therefore undertook structural studies of an endogenously expressed ESX-3 complex from the model organism *M. smegmatis* using cryo-electron microscopy (cryo-EM). During the preparation of this work for publication, a similar structure of the ESX-3 system expressed from a plasmid was published by another group ([@bib15]).

The ESX-3 translocon complex is important for iron acquisition ([@bib50]; [@bib51]), cell survival ([@bib57]), and virulence in pathogenic mycobacteria ([@bib59]), and its role in iron homeostasis is conserved in the model system, *M. smegmatis* ([@bib51]). The ESX-3 translocon complex proteins are transcribed in a single operon ([@bib35]), and expression of the ESX-3 operon is dependent on the transcriptional regulator IdeR, which controls iron metabolism ([@bib45]) and is required for growth in the human pathogen *M. tuberculosis* ([@bib39]). The ESX-3 operon is 67% identical between the non-pathogenic model organism *M. smegmatis* and the pathogen *M. tuberculosis* over the 4354 amino acids of the ESX-3 operon. This high degree of conservation and essential role in cell growth makes ESX-3 an important candidate for small molecule inhibition ([@bib8]), as blockade of ESX-3 will both inhibit virulence in *M. tuberculosis* and kill a broad range of pathogenic mycobacteria.

Results {#s2}
=======

A major innovation made possible by the dramatic improvements in cryo-EM ([@bib10]) is the ability to examine challenging protein samples at atomic resolution, even when samples are only available at low concentrations. When coupled with recent genetic manipulations that allow for facile insertion of chromosomal epitope and purification tags ([@bib38]), cryo-EM now holds the promise of routine structural characterization of many endogenously expressed protein complexes not previously tractable by structural techniques. We undertook the purification of the ESX-3 complex from the native host without the need for overexpression. To facilitate purification of the endogenous translocon complex, a cleavable EGFP tag was inserted into the chromosome of *M. smegmatis* mc(2)155 (wild type) and Δ*ideR* ([@bib11]) strains at the C-terminus of EccE~3~ via the ORBIT method ([@bib38]) ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). EccE~3~ is the final gene in the 11 gene long ESX-3 operon making insertion at this site less likely to disrupt regulation and expression of the operon. Deletion of the gene for the iron acquisition regulator IdeR greatly increases chromosomal expression of ESX-3 from negligible amounts of protein to a yield sufficient for purification and structure determination ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Components of ESX-3 were pulled down using an anti-GFP nanobody ([@bib48]) and the EGFP tag was proteolytically cleaved. After size exclusion chromatography, the peak fractions were pooled and analyzed biochemically and by cryo-EM .

Global structure of the ESX-3 dimer {#s2-1}
-----------------------------------

Four components of the ESX-3 translocon complex EccB~3~, EccC~3~, EccD~3~ and EccE~3~ were stably affinity-purified as a large molecular weight species of about 900 kDa ([Figure 1B and C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). The sample was imaged by cryo-EM and reconstructed revealing a dimeric structure, which can be divided into four areas: the flexible periplasmic multimerization domain, the stable transmembrane region, the stable upper cytoplasmic region, and the flexible lower cytoplasmic motor domain ([Figure 1D](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). While the peak fraction does not contain particles of a larger size consistent with higher order oligomers, thorough examination of the void volume revealed a small number of particles in a higher oligomeric state ([Figure 1---figure supplement 3A--E](#fig1s3){ref-type="fig"}). The resolution of the ESX-3 dimer varies substantially in different parts of the electron microscopy map and this heterogeneity was partially resolved through data processing ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} and [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). Initially, the entire ESX-3 dimer was reconstructed to 4.0 Å resolution ([Figure 1---figure supplement 6A](#fig1s6){ref-type="fig"}). Using symmetry expansion, and focused classification and refinement techniques, the resolutions of targeted regions of the ESX-3 complex were improved to 3.7 Å for the transmembrane region and upper cytoplasmic region ([Figure 1---figure supplement 6B--D](#fig1s6){ref-type="fig"}), 5.8 Å for the periplasmic region ([Figure 1---figure supplement 6E](#fig1s6){ref-type="fig"}), and \~7 Å resolution for the lower cytoplasmic region ([Figure 1---figure supplement 6F](#fig1s6){ref-type="fig"}). The highest resolution maps for each region were combined and filtered to the threshold of the lowest resolution map to form an overall 10 Å combination map for the entire ESX-3 dimer.

![Overview of the ESX-3 tagging, purification, and structure.\
(**A**) The ESX-3 operon in *M. smegmatis* and the placement of the purification tag. Genomic deletion of *ideR* derepresses ESX-3 to boost expression for purification. (**B**) SDS-PAGE of purified ESX-3 shows four major bands corresponding to EccB~3~, EccC~3~, EccD~3~, and EccE~3~. (**C**) Blue native page of the purified ESX-3 complex shows a large molecular weight band around 900 kDa. (**D**) Merged maps of all focused refinement maps (gray transparency) of the ESX-3 dimer filtered to 10 Å resolution. The transmembrane and upper cytoplasmic focused maps (3.7 Å) are segmented by subunit showing one copy per protomer of EccB~3~ (pink), EccC~3~ (blue), EccE~3~ (orange), EccD~3-bent~ (yellow), and EccD~3-extended~ (green). (**E**) Atomic models of the transmembrane and upper cytoplasmic regions. (**F**) A combined map of the full complex filtered to 10 Å resolution (gray transparency) with full models for each protein, EccD~3-bent~ (yellow), EccD~3-extended~ (green), EccE~3~ (orange), EccC~3~ (blue), and EccB~3~ (pink).](elife-52983-fig1){#fig1}

###### Data collection and refinement statistics.

Collection parameters for initial test data set and void peak analysis on the Talos Arctica and final collection on Titan Krios microscopes. Refinement details for initial model, consensus map, and focused refinements.

  Data Collection                                                                                                  
  ------------------------------------------ ----------------------------------- ------------------ -------------- ---------------
  Collection                                 Initial Screening                   Collection 1       Collection 2   Void peak
  Microscope                                 Talos Arctica                       Titan Krios        Titan Krios    Talos Arctica
  Voltage (kV)                               200                                 300                300            200
  Detector                                   Gatan K2                            Gatan K2           Gatan K2       Gatan K3
  Pixel size (Å/pixel)                       1.14                                0.82               0.82           0.9
  Exposure Time (s)                          9                                   10                 10             11.7
  Electron dose (e-/Å^2^)                    63                                  80                 67             58
  Defocus range (µm)                         1.5-2.5                             0.4-1.2            0.6-1.4        1.5-2.5
  Number of micrographs                      2,499                               2,705              4,632          1,215
  Consensus Reconstruction                                                                                         
  Data Set                                   Initial Screening                   Collection 1 & 2                  Void peak
  Software                                   Relion 2.1, cisTEM, and cryosparc   Relion 3.0                        cisTEM
  \# of particles, picked                    240,000                             778,149                           259,333
  \# of particles post, Class2D              138,000                             554,901                           640
  \# of particles post, Class3D              46,830                              362,438                           NA
  \# of particles post, skip align Class3D   NA                                  90,479                            NA
  Symmetry                                   C1                                  C1                                NA
  Map sharpening B-factor (Å^2^)             NA                                  -160                              NA
  Final resolution (Å)                       4.7 Å                               4.0 Å                             NA
  Focused Refinements                                                                                              
  Location of focus                          \# of particles                     Resolution                        
  Protomer i                                 76,967                              3.8                               
  Protomer ii                                90,479                              3.8                               
  Symmetry expanded protomer                 52,067                              3.7                               
  Periplasmic EccB3                          70,000                              5.8                               
  ATPase 1, 2, and 3                         30,000                              7                                 

The ESX-3 dimer is comprised of ten total proteins, two copies each of EccB~3~, EccC~3~, and EccE~3~ and four copies of EccD~3~. Two pseudo-symmetric protomers referred to as i and ii, combine to form the ESX-3 dimer. Each protomer contains one copy of EccB~3~, EccC~3~, and EccE~3~ and two conformationally distinct copies of EccD~3~, referred to as EccD~3-bent~ and EccD~3-extended~ ([Figure 1E](#fig1){ref-type="fig"}) based on their highly asymmetric conformations. At 3.7 Å resolution, it was possible to build *de novo* atomic models for all observable amino acids in the transmembrane and upper cytoplasmic regions, except the two transmembrane helices of EccC~3~ ([Figure 1E](#fig1){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The lower resolution regions of density, the EccC~3~ transmembrane helices, EccC~3~ ATPase 1, 2, and 3 domains and the EccB~3~ periplasmic domain, were flexibly fit using homology models. Using this hybrid approach, a model of the entire ESX-3 dimer has been produced ([Figure 1F](#fig1){ref-type="fig"}).

EccD~3~ forms a homodimer that encloses a large hydrophobic cavity {#s2-2}
------------------------------------------------------------------

There are two copies of EccD~3~ in each ESX-3 protomer ([Figure 2A](#fig2){ref-type="fig"}). The ubiquitin-like N-terminal domain of each EccD~3~ molecule interacts with EccE~3~ and EccC~3~ in the cytoplasm, and a long linker joins the soluble domain of EccD~3~ to 11 transmembrane helices ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A--F](#fig2s1){ref-type="fig"}). The four EccD~3~ molecules account for 44 of the total 54 transmembrane helices observed in the ESX-3 dimer. A distinct transmembrane cavity is formed by dimerization of the two copies of EccD~3~ in each protomer with a cross-sectional diameter of \~20×30 Å without significant regions of constriction. Transmembrane helices 1, 9 and 10 interact across the cavity dimer interface in a tight bundle making passive lipid transport into the membrane from the cavity unlikely ([Figure 2C](#fig2){ref-type="fig"}). The inner surface of the periplasmic half of the cavity is composed primarily of hydrophobic residues and in our maps, eight extended densities consistent with hydrophobic lipid tails or detergent molecules line the periplasmic inner face of the cavity ([Figure 2C](#fig2){ref-type="fig"}). In contrast, the cytoplasmic face of the cavity has several polar residues and ordered hydrophobic densities are not visible.

![The structure of EccD~3~.\
(**A**) EccD~3-bent~ (yellow) and EccD~3-extended~ (green) in the context of the overall ESX-3 dimer (gray transparency). (**B**) Atomic models of EccD~3-bent~ and EccD~3-extended~ (**C**) An unsharpened electron microscopy density map of the ESX-3 dimer shows extra densities consistent with lipid or detergent molecules (teal) on the periplasmic face of the EccD~3~ cavity. (**D**) EccD~3-bent~ (yellow) and EccD~3-extended~ (green) aligned based on the transmembrane regions shows two distinct conformations of the EccD~3~ cytoplasmic domains. Amino acids 100--127 of EccD~3~ adopt a bent (yellow) and an extended (green) conformation.](elife-52983-fig2){#fig2}

In the cytoplasm below the membrane, a stable, upper cytoplasmic region is formed by interactions between the soluble domains of EccD~3-bent~, EccD~3-extended~, EccE~3~, and EccC~3~. The linker joining the cytoplasmic ubiquitin-like domain to transmembrane helix 1 (residues 100--127) of EccD~3~ conserves a high sequence identity throughout evolution ([@bib3]), yet it adopts two distinct secondary structures resulting in the asymmetric placement of the cytoplasmic domains of EccD~3~ ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A--G](#fig2s1){ref-type="fig"}). In EccD~3-bent~, residues 100--127 are bent, folding into an α-helix and forming a nexus of stabilizing contacts with EccB~3~ and EccC~3~ ([Figure 2---figure supplement 1H](#fig2s1){ref-type="fig"}). In EccD~3-extended~, residues 100--127 are extended and fold into a shorter α-helix that interacts with EccE~3~ and the cytoplasmic domain of EccD~3-bent~ ([Figure 2---figure supplement 1I](#fig2s1){ref-type="fig"}). This conformational flexibility suggests that if residues 100--127 were released from their associations with EccC~3~ and EccE~3~ they could rearrange into the alternative bent or extended conformation with little energetic barrier.

EccC~3~ and EccE~3~ make extensive, stabilizing interactions with the asymmetric, cytoplasmic domains of EccD~3~ {#s2-3}
----------------------------------------------------------------------------------------------------------------

The next component of the stable upper cytoplasmic region is EccE~3~. EccE~3~ is positioned at the front of the ESX-3 dimer ([Figure 3A](#fig3){ref-type="fig"}), where the conserved transmembrane helix 1 of EccE~3~ interacts with helix 11 of EccD~3-bent~ in the membrane. Helix 1 is followed by a second EccE~3~ transmembrane helix, a linker helix, and then extends into the cytoplasm ([Figure 3B and C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A--D](#fig3s1){ref-type="fig"}). The anti-parallel β-sheets of the cytoplasmic domain of EccE~3~ have weak structural homology to glycosyl transferase proteins, however, the nucleotide binding pocket is absent in EccE~3~, leaving it incapable of performing this function ([Figure 3---figure supplement 1E and F](#fig3s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). EccE~3~ does not have another obvious ligand or catalytic site. Two conserved helices in the cytoplasmic region of EccE~3~ between amino acids 133 and 163 form extensive stabilizing interactions with both subunits of EccD~3~ ([Figure 3D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}). These interactions hold the flexible linker of EccD~3-extended~ in the extended conformation and sterically hinder EccD~3-extended~ from assuming the bent conformation ([Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}). EccE~3~ does not form direct protein-protein interactions with either EccB~3~ or EccC~3~ suggesting the contacts with EccD~3-extended~ and EccD~3-bent~ are extremely stable as EccE~3~ was the tagged protein used to immunoprecipitate the ESX-3 dimer.

![The structure and protein-protein interactions of EccE~3~.\
(**A**) The placement of EccE~3~ in the overall ESX-3 dimer. (**B**) Atomic model of EccE~3~ (**C**) Transmembrane helix 1 of EccE~3~ interacts with transmembrane helix 11 of EccD~3-bent~ (**D**) Two soluble helices of EccE~3~ interact with EccD~3-extended~ and EccD~3-bent~.](elife-52983-fig3){#fig3}

The final component of the stable upper cytoplasmic region is the domain of unknown function (DUF) of EccC~3~. EccC~3~ extends from the membrane into the upper and lower cytoplasmic regions ([Figure 4A](#fig4){ref-type="fig"}). Amino acids 1--33 and 94--403 of EccC~3~ were built *de novo* into the higher resolution region of the electron microscopy map revealing the structure of the DUF domain ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}). The *de novo* model of the DUF has the typical Rossman fold of a nucleotide hydrolysis domain ([Figure 4---figure supplement 1D and E](#fig4s1){ref-type="fig"}) and its closest homolog by Dali search is the ATPase 1 domain of EccC of *T. curvata*. It is linked to the transmembrane domains by a long helical bundle making extensive contacts with the flexible linker region of EccD~3-bent~ ([Figure 4C](#fig4){ref-type="fig"}). The DUF makes additional stabilizing contacts with the ubiquitin-like domains of EccD~3-bent~ and EccD~3-extended~ in the cytoplasm ([Figure 4D](#fig4){ref-type="fig"}).

![The structure and protein-protein interactions of EccC~3~.\
(**A**) The placement of EccC~3~ in the overall ESX-3 dimer. (**B**) Atomic model of the EccC~3~ DUF (**C**) The stalk helices of EccC~3~ interact with EccB~3~, EccD~3-bent~, and EccD~3-extended~ (**D**) Interactions between EccC~3~ and the ubiquitin-like domains of EccD~3-bent~ and EccD~3-extended~ in the cytoplasm.](elife-52983-fig4){#fig4}

When the transmembrane and upper cytoplasmic regions are compared between protomers, only the transmembrane helices of EccC~3~ and the N-terminal tail of EccB~3~ differ ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}), otherwise the protomers are superimposable. All four EccC~3~ transmembrane helices were modeled at 6 Å resolution through a combination of homology modeling and molecular dynamics. In protomer i, transmembrane helix 2 forms lipid mediated hydrophobic interactions with the transmembrane helix of EccB~3~ in protomer i, and transmembrane helix 1 interacts with transmembrane helix 2 of EccC~3~ in protomer ii. Transmembrane helix 1 of EccC~3~ in protomer ii is shifted relative to the protomer i conformation and does not directly interact with other proteins.

The EccC~3~ motor domains are flexible and asymmetric across the dimer {#s2-4}
----------------------------------------------------------------------

The motor domains containing the EccC~3~ ATPase 1, 2 and 3 hang below the DUF domain in the flexible lower cytoplasmic region. They were resolved at a lower resolution than the upper cytoplasmic domain, but they are clearly asymmetric between protomers i and ii ([Figure 4A](#fig4){ref-type="fig"}). Although the EccC~3~ ATPase 1 domains in both protomers are in a similar location relative to the DUF, the ATPase 2 and 3 domains do not superimpose across protomers even at low resolution ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}) suggesting significant asymmetry between these domains. In protomer i, a homology model based on existing EccC structures fits well into the density; however in protomer ii, the interface between ATPase 1 and 2 is broken relative to the crystal structure with ATPase 2 and ATPase 3 rotated away from the crystal structure interface.

EccB~3~ extends into the periplasm and stabilizes dimer formation {#s2-5}
-----------------------------------------------------------------

The ESX-3 dimer is stabilized by cross-protomer interactions formed by the two EccB~3~ proteins. EccB~3~ begins in the cytoplasm with a flexible N-terminal tail leading into a linker helix, followed by a single-pass transmembrane helix, and an extended periplasmic domain ([Figure 5A and B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). The N-terminal tail of EccB~3~ from protomer i forms extensive cross-protomer contacts with EccB~3~, EccC~3~, EccD~3-bent~ and EccD~3-extended~ from protomer ii ([Figure 5C](#fig5){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). The linker helix of EccB~3~ forms further protein-protein interactions with EccC~3~ and EccD~3-bent~. The transmembrane helix of EccB~3~ interacts with transmembrane helix 11 of EccD~3-extended~. Two hydrophobic tails consistent with a lipid or detergent molecules link the transmembrane helix of EccB~3~ to transmembrane helix 2 of EccC~3~ ([Figure 5D](#fig5){ref-type="fig"}). The two EccB~3~ periplasmic domains share a large interaction interface across the protomers further stabilizing dimerization. Homology models of two EccB~3~ proteins can be docked into the periplasmic domain ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}); however, this region is not resolved sufficiently to identify specific interactions. The majority of cross-protomer interactions involve EccB~3~, suggesting the periplasmic domain is essential for oligomerization.

![The periplasmic multimerization domain.\
(**A**) EccB~3~ (pink) in the context of the overall ESX-3 dimer (gray transparency). EccB~3~ has a single-pass transmembrane domain which extends into a large periplasmic domain which was resolved at 5.8 Å resolution. (**B**) Atomic models of the EccB~3~ cytoplasmic and transmembrane domains, amino acids 14--93 and 32--93. (**C**) The N-terminus of EccB~3~ forms extensive cross-protomer contacts with EccC~3~ (blue), EccD~3-bent~ (yellow), and EccD~3-extended~ (green). (**D**) An unsharpened map of the ESX-3 dimer reveals ordered densities consistent with lipids or detergent molecules mediating the interactions between the EccB~3~ transmembrane helix (marked with a pink dot) and the EccC~3~ transmembrane helices.](elife-52983-fig5){#fig5}

A hexameric model of ESX-3 {#s2-6}
--------------------------

Previous reports have shown ESX-1 and ESX-5 form hexamers or higher order multimers ([@bib5]; [@bib24]). We modeled a higher order oligomeric state of ESX-3 based on the low-resolution negative stain structure of ESX-5, which had C6 symmetry imposed during refinement (EMDB 3596). The ESX-3 translocon complex was modeled as a trimer of dimers by low pass filtering the density to 6 Å and docking into the ESX-5 negative stain map ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). The model of the ESX-3 dimer transmembrane and upper cytoplasmic regions, including the EccC~3~ transmembrane helices modeled to 6 Å resolution, was fitted into the trimerically positioned ESX-3 density maps ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). The angle between protomers in the trimer of dimers model alternates between 72° (the angle between protomers i and ii in the ESX-3 dimer map) and 48° and contains both experimentally observed conformations of EccC~3~. The complete model of the ESX-3 translocon complex was docked into the ESX-5 negative stain map in the same manner revealing major clashes between the low resolution periplasmic and motor domains in a hexameric form ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). Accommodation of a hexameric complex would require extensive rearrangement of both EccC~3~ and EccB~3~.

Discussion {#s3}
==========

The ESX-3 structure presented here is purified without the addition of substrates or nucleotide. It is therefore likely to be in a conformation representing the end of the translocation cycle, awaiting either the direct binding of substrates, the binding of nucleotide or both, to reset a substrate-binding competent state. By fitting our dimer structure into a prior low resolution envelope we suggest a model of the oligomeric state of the complex, in close agreement with Famelis et al. However, even allowing for major rearrangements in the more flexible regions of EccC~3~ and EccB~3~, a model built by the static trimerization of the experimentally determined dimer structure cannot itself explain the mechanism of action of ESX-3 secretion. The existence of an R-finger catalytic site for ATPase 1 of EccC~3~ ([@bib47]) requires the R-finger of one protomer to insert into the active site of another protomer. Given the \~65 Å distance we observe between ATPase 1 domains, the completion and activation of the catalytic site of ATPase 1 by an R-finger will necessitate an extremely large rearrangement of the position of the ATPase domains. How might this rearrangement occur? We propose movements in the highly flexible EccD~3~ linker lead to the release of EccE~3~ and EccC~3~ from their rigid positions, thus allowing for a rearrangement of the ATPase domains into an active conformation ([Figure 6](#fig6){ref-type="fig"}).

![Two models of the ESX-3 translocon complex.\
ATPase activity entails, at a minimum, oligomerization of ATPase 1 to bring the R-finger (R) into proximity of the catalytic site, marked by the Walker A motif (WA). This requires at least 65 Å of movement from the position seen in the structure. (A) The first model of ESX substrate secretion involves trimerization of the ESX-3 dimer followed by multimerization of the EccC ATPase domains into a stack of one to four rings of ATPases (B) The second model shown through the function of a single protomer of the ESX-3 complex. Substrates are selected by interaction with ATPase 3 of EccC and transported via the upper cytoplasmic region to the EccD cavity for secretion.](elife-52983-fig6){#fig6}

Once EccC~3~ assembles into an oligomeric state, the substrate proteins will need to translocate through the inner membrane. We have considered two models for how pore formation and transit might occur: 1) through a pore created by the oligomerization of EccC~3~ and EccB~3~ or 2) through the large cavity created by the dimerization of EccD~3~. In the first model ([Figure 6A](#fig6){ref-type="fig"}), the resting state of an ESX translocon complex is a hexamer, with disordered EccC~3~ ATPase domains free in the cytosol, stabilized by interactions with proteins not seen in the structures presented here ([@bib60]). It is possible the rare multi-dimer oligomeric state we see in the void volume, and also seen by Famelis et al., represents this state. In a hexamer model, the center of the multimer is formed by the transmembrane helices of EccC~3~ and EccB~3~, which create a cavity that could serve as a pore for translocation of substrates. These transmembrane helices are largely hydrophobic and do not contain obvious residues that would allow for the conductance of hydrated substrates. Thus the production of a protein transit channel would require either a large, conformational change in the transmembrane helices, likely facilitated by movements in the cytoplasmic domains of EccC~3~, EccD~3~ and EccE~3~, or a novel mechanism of action for transit through the central pore.

A hexameric pore created by EccC~3~ agrees well with the documented mechanism of action for motor ATPases in the additional strand catalytic E (ASCE) division of P-loop NTPases ([@bib14]), which includes EccC~3~. A hexameric pore also agrees with the proposed mechanism of action for other bacterial secretion systems, such as the Type IV secretion system VirD4 coupling protein ([@bib18]; [@bib23]), which is related evolutionarily to EccC~3~ ([@bib27]). The hexamer model is thus firmly grounded in the motor ATPase and bacterial secretion systems literature, although the oligomeric state of VirD4 has recently been called into question ([@bib43]) and remains controversial ([@bib36]).

In a second, more speculative model, EccD~3~ dimers form a channel for translocation of substrates ([Figure 6B](#fig6){ref-type="fig"}). The large cavity found in the EccD~3~ dimer is striking and by structural homology, is unlike any other membrane protein in the Protein Data Bank. In our density maps, the EccD~3~ dimer cavity appears capped on the periplasmic side by a dense layer of lipids. In contrast, on the cytoplasmic side the cavity does not exhibit bound lipids due to the polar residues lining the lower half of the cavity. The large cavity is of sufficient diameter to transit a folded EsxG/H dimer, however given the strong hydrophobicity of the cavity the mechanism would not be mediated by water and would require a novel mechanism of secretion that has not been seen in other bacterial secretion systems. It is also possible that the cavity exists to transit a non-protein substrate such as a specific mycobacterial lipid. The ability to transport non-protein substrates could resolve some of the mysteries that remain about the relationships between ESX systems, cell wall stability, lipid content, and nutrient acquisition ([@bib4]; [@bib7]; [@bib52]; [@bib59]).

As each protomer contains an EccD~3~ cavity, the second model, proposing translocation through EccD~3~, does not require hexamerization. However, this model is also not incompatible with hexamerization, which would not block a substrate path through EccD~3~. Further, the role of the hexamer may not be to form a central channel for substrate transit. Rather, hexamerization could serve some other purpose. For example, it may tether functional dimers together, facilitate localization, or increase local concentration and allosteric control of enzymatic activity ([@bib33]).

Although the ESX-3 structure presented here allows for mechanistic hypotheses about the transit of substrates across the inner-membrane, it does not provide sufficient information to allow for a structural model of transit across the outer mycomembrane. The EccB~3~ periplasmic domain ([@bib63]) has been found to have similarity to the peptidoglycan binding phage protein PlyCB, which forms a ring inside the bacterial cell wall facilitating phage entrance into the cell. A hypothesis is that EccB~3~ is anchored to a larger outer membrane complex, but the purification conditions we have employed remove proteins required for its stabilization.

The description of ESX-3 presented here agrees in both protein composition and structure with the work recently published by Famelis et al. Given the high sequence conservation among the ESX systems in mycobacteria and related actinobacteria, these structures likely represent an excellent framework for the structural modeling of the other ESX systems. Together, these structures provide a wealth of information about protein-protein interaction interfaces and ESX complex architecture, which can be used to guide structure-based drug design and to generate hypotheses for further mechanistic investigations.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                     Designation                                               Source or\                           Identifiers                Additional\
  or resource                                                                                           reference                                                       Information
  ------------------------------------------- --------------------------------------------------------- ------------------------------------ -------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Biological sample Mycobacterium smegmatis   *mc(2)155*                                                ATCC                                 700084                     Wild type strain

  Biological sample Mycobacterium smegmatis   *mc(2)155 with ideR::mγδ200 (KanR)*                       [@bib11], Provided by GM Rodriguez                              

  Biological sample Mycobacterium smegmatis   *mc(2)155, MSMEG_0626-3C-EGFP*                            This paper                                                      

  Biological sample Mycobacterium smegmatis   *mc(2)155 with ideR::mγδ200 (KanR), MSMEG_0626-3C-EGFP*   This paper                                                      

  Recombinant DNA reagent                     pKM444                                                    [@bib38]                             Addgene Plasmid \#108319   Plasmid encoding for Che9c phage RecT and Bxb1 phage Integrase

  Recombinant DNA reagent                     pKM444 - zeo                                              This paper                                                      Addition of zeocin resistance cassette to pKM444 plasmid

  Recombinant DNA reagent                     pKM468-3C-EGFP                                            This paper                                                      Modified ORBIT tagging plasmid 

  Sequenced-based reagent                     ORBIT targeting oligonucleotide                           This paper                           Oligo                      5' TGTGCGTTCCACTGGTTCCCCGGCAACCACCTGCTGCACGTGAGCCAGCCGGACTACCTAGGTTTGTACCGTACACCACTGAGACCGCGGTGGTTGACCAGACAAACCCGCCGGATGACCCGCTTCCTGCGCGGCTTCATGTTCGACTGAACCCTTCACCGAGGTCCG 3'

  Antibody                                    Anti-GFP stabilized antibody preparation                  Roche                                Cat. \#: 11814460001       Dilution 1:10000

  Antibody                                    Anti-mouse IgG HRP-conjugated antibody                    R&D Systems                          Cat. \#: HAF007            Dilution 1:5000

  Antibody                                    Goat anti-rabbit IgG antibody HRP                         GenScript                            Cat. \#: A00098            Dilution 1:5000

  Antibody                                    Rabbit anti-GroEL                                         Sigma-Aldrich                        Cat. \#: G6532-.5ML        Dilution 1:5000

  Peptide, recombinant protein                Human Rhinovirus (HRV) 3C Protease                        Thermo Scientific Pierce             Cat. \#: 88946             

  Commercial assay or kit                     Superose 6 Increase 10/300 GL                             GE Healthcare                        Cat. \#: 29091596          

  Chemical compound, detergent                DDM, n-Dodecyl-β-D-Maltopyranoside                        Inalco                               Cat. \#: 1758-1350         

  Chemical compound, detergent                GDN, glyco-diosgenin                                      Anatrace                             Cat. \#: GDN101            

  Other                                       NativePAGE 3-12% Bis-Tris Protein Gels, 1.0 mm, 10-well   ThermoFisher Scientific              Cat. \#: BN1001BOX         

  Commercial assay or kit                     Pierce Silver Stain Kit                                   Pierce                               Cat. \#: PI24612           

  Software, algorithm                         SerialEM                                                  [@bib37]                                                        <https://bio3d.colorado.edu/SerialEM/>

  Software, algorithm                         MotionCor2                                                [@bib65]                                                        <http://msg.ucsf.edu/em/software/motioncor2.html>

  Software, algorithm                         CTFfind4                                                  [@bib46]                                                        <https://grigoriefflab.umassmed.edu/ctffind4>

  Software, algorithm                         RELION                                                    [@bib49]                                                        [cam.ac.uk/relion/index.php/Download\_%26_install](https://www3.mrc-lmb.cam.ac.uk/relion/index.php/Download_%26_install)

  Software, algorithm                         cisTEM                                                    [@bib19]                                                        <https://cistem.org/>

  Software, algorithm                         cryosparc                                                 [@bib42]                                                        <https://cryosparc.com/docs/reference/install/>

  Software, algorithm                         pyem                                                      [@bib2]                                                         <https://github.com/asarnow/pyem>

  Software, algorithm                         coot                                                      [@bib13]                                                        [https://www2.mrc-lmb.cam.](https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/)

  Software, algorithm                         raptorX                                                   [@bib28]                                                        <http://raptorx.uchicago.edu/>

  Software, algorithm                         phenix real space refine                                  [@bib1]                                                         [https://www.phenix-online.](https://www.phenix-online.org/documentation/reference/refinement.html)

  Software, algorithm                         MDFF                                                      [@bib58]                                                        [org/documentation/reference/refinement.html](https://www.phenix-online.org/documentation/reference/refinement.html)

  Software, algorithm                         namdinator                                                [@bib29]                                                        <https://namdinator.au.dk/>

  Software, algorithm                         pisa                                                      [@bib32]                                                        <http://www.ccp4.ac.uk/pisa/>

  Software, algorithm                         chimera                                                   [@bib40]                                                        <https://www.cgl.ucsf.edu/chimera/>

  Software, algorithm                         chimeraX                                                  [@bib17]                                                        <https://www.cgl.ucsf.edu/chimerax/>

  Software, algorithm                         DALI                                                      [@bib22]                                                        <http://ekhidna2.biocenter.helsinki.fi/dali/>\
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Strain construction {#s4-1}
-------------------

*Mycobacteria smegmatis* mc(2)155 (wild type) and Δ*ideR* cells were chromosomally tagged using the ORBIT protocol ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). For wild type cells, the integrase and annealase expressing plasmid was pKM444. For recombineering in the Δi*deR* strain, which already contained a kanamycin resistance marker, we created a modified pKM444 plasmid with a zeocin resistance cassette inserted at the EcoIV restriction site. The tagging plasmid was pKM468 with a 3C protease cleavage site added before the EGFP tag. The targeting oligo had the sequence: 5' TGTGCGTTCCACTGGTTCCCCGGCAACCACCTGCTGCACGTGAGCCAGCCGGACTACCTAGGTTTGTACCGTACACCACTGAGACCGCGGTGGTTGACCAGACAAACCCGCCGGATGACCCGCTTCCTGCGCGGCTTCATGTTCGACTGAACCCTTCACCGAGGTCCG 3'. *M. smegmatis* cells containing pKM444 were grown in an overnight liquid culture and induced for annealase and integrase expression. Cells were prepared for electroporation and electroporated with the targeting oligo and tagging plasmid. The transformed *M. smegmatis* were plated on hygromycin (wild type) or hygromycin and kanamycin (Δ*ideR*) containing 7H9 plates and incubated at 37° C for 3 days. Colonies were verified for insertion of the tagging plasmid into the chromosome by PCR.

Western blotting {#s4-2}
----------------

100 mL of EccE~3~ tagged wild type and Δ*ideR* knock out cells were grown overnight to an OD~600~ of 1.0--1.2. Cells were pelleted and resuspended in 1 mL of buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% DDM) and sonicated for 30 s. Cell lysates were run on a 4--20% SDS-PAGE gel (GenScript) and transferred to PVDF membrane (BioRad) using a BioRad Trans-Blot Turbo Transfer System. The blot was washed with PBS and blocked in a 5% milk/PBS-T solution for 1 hr. The blot was incubated with mouse anti-GFP monoclonal antibody (Roche) overnight. After rinsing with PBS-T, the blot was incubated with anti-mouse IgG HRP-conjugated antibody (R&D Systems) for 2 hr. After activation (Amersham) the blot was imaged on a BioRad ChemiDoc. The blot was stripped with stripping buffer (ThermoFisher Scientific) as per the manufacture\'s instructions, and incubated overnight with rabbit anti-GroEL monoclonal antibody (Sigma-Aldrich). The blot was incubated with goat anti-rabbit IgG antibody HRP (GenScript) for 2 hr, activated (Amersham), and imaged on a BioRad ChemiDoc.

Protein purification {#s4-3}
--------------------

Purification for high resolution structural determination: *M. smegmatis* was grown in 6 L of 7H9 supplemented with 0.05% Tween 80 and 20 µg/mL kanamycin to an OD~600~ of \~0.8. After harvest, cells were washed three times with PBS and frozen in liquid nitrogen before lysis with a cryogenic grinder (SPEX SamplePrep). 24.9 g of powdered cell material was resuspended by adding 56.3 mL 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% DDM supplemented with 1X protease inhibitor cocktail (SigmaFast) and 224 units Benzonase endonuclease. The suspension was stirred for 120 min at 4°C. After centrifugation for 30 min at 98,000 g, the supernatant was incubated with 1.4 mL anti-GFP-nanobody resin for 110 min at 4°C. The resin was transferred to a column and washed sequentially with 28 ml of wash buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.1% GDN), 14 mL of high salt wash buffer (50 mM Tris-HCl pH 8.0, 400 mM NaCl, and 0.1% GDN), and 14 mL of wash buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.1% GDN). To cleave off the purification tag, the resin was incubated o/n at 4°C with 70 units Pierce HRV 3C protease (Thermo Scientific Pierce) in 2.8 mL wash buffer supplemented with 0.2 mM DTT. This resin was sedimented by gentle centrifugation (300 x g for 3 min), the supernatant collected, and the resin was subsequently washed with 1.4 mL wash buffer. The supernatant and wash fraction were combined and concentrated using an Amicon Ultra-4 centrifugal filter unit with a 100 kDa molecular weight cut-off. The sample was centrifuged at 16,000 g before injection on a Superose 6 10/300 column equilibrated in 50 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.021% GDN. Peak fractions were concentrated using a 0.5 mL centrifugal filter unit (Amicon, 100 kDa cut-off) to an A280 of 5.52 by Nanodrop reading in about \~30 µL . Purification completed for examination of the void fractions was similar except: volumes were scaled for a powder weight of 21.1 g. and the high salt wash was omitted.

Blue-Native polyacrylamide gel electrophoresis (BN-PAGE) {#s4-4}
--------------------------------------------------------

BN-PAGE experiments were carried out using the Invitrogen NativePAGE Novex Bis-Tris Gel system as recommended by the manufacturer. Samples were prepared in a total volume of 10 µL using 0.5 µL 5% G-250 sample additive. Electrophoresis was performed at a constant voltage of 105-120 V for 2-3.5 hr at 4°C. The gel was fixed and stained using the Pierce silver stain kit.

Cryo-EM -- data acquisition {#s4-5}
---------------------------

Samples were frozen for cryo-EM. Quantifoil R1.2/1.3, 400 mesh, copper grids were glow discharged using a Solarus plasma cleaner (Gatan) with an H~2~/O~2~ mixture for 30 s. 2 µL of sample were applied per grid and the grids were plunged into liquid ethane using a FEI Vitrobot Mark IV.

Initially, samples were screened, and test data sets were collected on a FEI Talos Arctica 200kV microscope equipped with a Gatan K2 Summit detector. For the initial screen of freezing conditions, 2499 movies were collected at a magnification of 36,000 with a pixel size of 1.14, and a defocus range of −1.5 to −2.5 µm, an exposure time of 9 s, and a dose rate of 7 electrons/Å^2^/second ([Table 1](#table1){ref-type="table"}). Data collection for the final structure presented in the main text was collected on a FEI Titan Krios at 300kV with a Gatan K2 Summit detector. Two imaging sessions were used. In the first imaging session, 2705 movies were collected at a magnification of 29,000 with a pixel size of 0.82, and a defocus of −0.4 to −1.2 µm, an exposure time of 10 s to collect 100 total frames, and a dose rate of 8 electrons/Å^2^/second ([Table 1](#table1){ref-type="table"}). In the second imaging session, data was collected on the same microscope with the same detector, 4632 movies were collected at a magnification of 29,000 with a pixel size of 0.82, and a defocus range of −0.6 to −1.4 µm, an exposure time of 10 s to collect 80 total frames, and a dose rate of 6.7 electrons/Å^2^/second. Data used to analyze the void, plateau, and peak regions of the SEC profile were collected on a FEI Talos Arctica at 200kV with a Gatan K3 detector. All micrographs were collected at a magnification of 28,000 with a pixel size of 0.9, and a defocus range of −1.5 to −2.5 µm, an exposure time of 11.7 s to collect 117 total frames at a total dose of 58 electrons/ Å^2^. For the void region, 1215 micrographs were collected.

Cryo-EM -- data processing {#s4-6}
--------------------------

For all data, movies were motion corrected using MotionCor2 ([@bib65]) and CTF correction was performed using CTFfind4 ([@bib46]). For the Arctica dataset, particles were picked using a gaussian blob in either RELION ([@bib66]) or cisTEM ([@bib19]) and initial 2D classification was performed to remove obvious artifactual particles. Initially, a shotgun approach was taken to generate several initial models using RELION, cisTEM, and cryosparc ([@bib42]). Once an initial model which contained realistic low-resolution features was generated, a user defined descent gradient was performed to improve the model with the goal of achieving accurate secondary structure features. First, all particles selected during 2D classification were refined in 3D against the randomly generated initial model. Second, a round of 3D classification with four classes and default RELION settings was performed and the best class selected. Third, the best class was refined as a single class in 3D classification with increasing Tau2_Fudge and decreasing search angle size. The resulting EM density map had clear transmembrane helix densities and was used as the model for a new 3D reconstruction. This reconstruction was used to back project models for reference-based particle picking in RELION. Two rounds of 2D classification were performed and the best classes selected. One round of 3D classification was performed using the Tau2_Fudge value optimized during the previous run through (T = 12) and the best class selected. A final 3D reconstruction of the Arctica data set yielded a map of about 4.7 Å resolution ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}).

After motion correction and CTF determination, the final Titan Krios dataset was processed entirely using RELION. Particles were picked using a gaussian blob, and extracted as 4x binned particles. Two rounds of initial 2D classification were performed with T = 3 on the binned particles and obvious artifactual particles were removed. The final reconstruction from the Arctica dataset was used as the initial model for a 3D reconstruction of the binned particles. 3D classification with four classes and the previously optimized Tau2_Fudge value, T = 12, was performed on the binned particles. The two best classes were selected and re-extracted without binning. A 3D reconstruction was performed. A mask was created for the high-resolution region of the reconstruction and 3D classification without image alignment was performed focused on this region. The best class was selected and the subsequent 4.0 Å reconstruction is the consensus structure for the entire complex ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). Focused classification of each protomer, the periplasmic EccB region, and the ATPase 1, 2, and 3 domains of EccC were performed. To perform focused classification, the center of mass of the region of interest was determined using chimera ([@bib40]). Particles were recentered on this area and reextracted. Masks for the region of interest were generated and 3D classification without image alignment was performed. The best class was selected and used for a focused 3D reconstruction without image alignment of the region of interest. A reconstruction was generated and density outside of the region of interest was subtracted. A final reconstruction of the masked and density subtracted particles was then performed. This procedure improved the resolution of the protomer i to 3.75 Å and protomer ii 3.83 Å, 5.8 Å resolution for the EccB~3~ periplasmic domain, and \~7 Å resolution for the EccC~3~ lower cytoplasmic region.

To generate the symmetry expanded protomers based on non-point group symmetry (also known as non-crystallographic symmetry or NCS), a transformation matrix between the two protomers was calculated using chimera. Particles were then transformed and aligned using the subparticles.py and star.py utilities in pyem ([@bib2]) resulting in a particle stack with twice as many particles as the input file, each focused on protomer i or protomer ii. Density subtraction was performed to remove density outside of the symmetry expanded protomer, and focused classification and refinement were performed as described above. This procedure improved the resolution of the symmetry expanded protomer to 3.69 Å resolution.

Atomic model building {#s4-7}
---------------------

The cytoplasmic domain from the crystal structure of EccD~1~ (PDB 4KV2) was docked into the cytoplasmic domains of the two EccD~3~ molecules and the sequence was mutated. The remaining transmembrane domains of EccD~3~ and the residues 14--93 of EccB~3~ were built *de novo* in Coot ([@bib13]) using baton building. The alpha helices of EccE~3~ and EccC~3~ were initially modeled using the RaptorX ([@bib28]) homology server. The loops and strands of EccE~3~ and EccC~3~ were built in Coot using baton building. All models were subsequently refined individually, as a symmetry expanded protomer, left and right protomers, and as the full model using phenix real space refine ([@bib1]), Coot, and the MDFF ([@bib58]) server, Namdinator ([@bib29]; [Supplementary file 1](#supp1){ref-type="supplementary-material"}).

Low resolution modeling {#s4-8}
-----------------------

The left and right protomer map, periplasmic focused refined map, and lower cytoplasmic focused refined map were all docked into the consensus map and added together using chimera. The combined map was filtered to 10 Å resolution to match the lowest resolution component. Homology models for amino acids 94--516 of EccB~3~, the transmembrane helixes of EccC~3~, and 404--1268 of EccC~3~ were generated using RaptorX. These models were fit into the combined map density using the fit map to model utility in Chimera. The full model was refined using phenix.real_space_refine.

Model interpretation and display {#s4-9}
--------------------------------

Buried surface area between subunits was calculated by PISA ([@bib32]). Atomic models for individual proteins were compared against the PDB using the DALI server ([@bib22]). Chimera and ChimeraX ([@bib17]) were used to display maps and models for figure creation. Consurf ([@bib3]) was used to produce multisequence alignments and to color structural models by homology.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This manuscript by Poweleit et al. describes the cryoEM structure of a natively purified ESX-3 (Type VII) secretion system from *Mycobacterium smegmatis*. Our understanding of the type VII secretion mechanism has been limited by the lack of high-resolution structural information of the fully assembled, \~900 kDa machine. Here the authors isolate the native ESX-3 complex from *M. smegmatis* and solve the structure by single-particle cryoEM in detergent. This is a beautiful and informative structure, and the analysis is rigorous. The work is significant because it corroborates the structural observations recently published by a competing group (Famelis et al., 2019), and provides a framework for understanding how this secretion machine transports its folded clients across the cytoplasmic membrane.

**Decision letter after peer review:**

Thank you for submitting your article \"The native structure of an ESX translocon\" for consideration by *eLife*. Your article has been reviewed by four peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Richard Aldrich as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript by Poweleit et al. describes the high-resolution structure of an ESX-3 complex of *M. smegmatis* obtained by cryo-electron microscopy. A virtually identical structure of the same complex has been published in Nature by Famelis et al. as the authors were preparing to submit this paper. In contrast to the structure published by Famelis et al., which was obtained by overexpressing the ESX-3 system from a plasmid, Poweleit et al. tagged the complex chromosomally, on the last gene (EccE) of the operon, to bypass potential transcriptional defects. While the presented work therefore represents a native structure, as opposed to the already published structure by Famelis and colleagues, the observed structural features/composition are the same for both structures. It was felt that the *eLife* policy on \"scoops\" protects the authors of this manuscript and that it therefore should be considered further after suitable revisions.

Essential revisions:

1\) The authors fail to see any higher order oligomers, which have been previously reported in native (Houben et al., 2012, van Winden et al., 2016) and also plasmid expressed conditions (Famelis et al., 2019; Beckham et al., 2017). These publications have reported higher order oligomers in multiple mycobacterial species (*M. bovis* BCG, *M. marinum* and *M. smegmatis*) and from different type VII secretion systems (ESX-1, ESX-3 and ESX-5). Higher order multimerization has also been suggested/observed by the corresponding author in previously published work (Rosenberg et al., 2015) for the EccC ATPase. Importantly, Beckham et al. and Famelis et al. showed that these higher order oligomers are only present in the void peak fraction of the SEC analysis. In the current study it is unfortunately not mentioned which SEC fractions were used for the cryo-EM analysis, but it is suspected that the void peak fractions were not analyzed. To confirm that the native ESX-3 complex forms higher order oligomers, the authors should more thoroughly investigate the presence of these multimers, e.g. by including the void peak fractions in the analysis and/or analyzing the ESX-3 membrane complex by BN-PAGE analysis before SEC (including crosslinking).

2\) The authors propose an alternative and contentious model for protein translocation through the membrane complex, i.e. through a hydrophobic cavity formed by two EccD subunits, which is (partially) filled with lipids. Indeed, the presence of such a large cavity in between these two subunits is striking. However, the surface of this cavity consists, except for a number of polar residues, solely of hydrophobic residues. In agreement with a hydrophobic interface, the structure reveals extra densities at the periplasmic part of the cavity suggesting the presence of lipids or detergent. The cytoplasmic half of the cavity does not reveal these extra densities, which could be caused by the presence of several polar residues here, as also discussed by the authors. However, lipids in this part of the cavity could have been removed during solubilization of the complex. To show that partially lipid-filled cavities have been observed also in other membrane complexes, the authors refer to a publication describing the presence of a similar lipid plug in the central cavity of a reconstituted rotor cylinder of the ATP synthase (Meiers et al. Febs Lett 2001). However, it is explicitly mentioned in this article that \"As the detergent-purified c cylinder is completely devoid of phospholipids, these are incorporated into the central hole from one side of the cylinder during the reconstitution procedure\". It therefore remains unclear whether such lipid-plugged membrane pores actually exists in vivo. In addition, Poweleit et al. propose a \"lipid mediated\" mechanism of protein translocation through this hydrophobic pore. It is difficult to envision though how lipids would be able to mediate translocation of folded substrate dimers with mostly hydrophilic surfaces. This would be a completely new mechanism of protein translocation not seen for any other protein secretion machineries. In addition, the authors speculate even further that besides (hydrophilic) proteins also hydrophobic molecules, such as lipids, could be transported through this cavity, while there is no clear evidence that type VII secretion systems are able mediate lipid transport. In conclusion, while it is indeed striking that such a large cavity is present in the ESX-3 complex, the authors should more cautiously discuss this model, by also mentioning the major problems with this model as discussed above. The translocation model of substrates through the central pore of a hexameric complex is far less speculative, as it is supported by experimental data, published by several groups (as also mentioned in the Discussion). This model should therefore get more emphasis.

3\) The regulatory role of the \"cytoplasmic bridge\" is speculative and should be more carefully discussed. e.g. \"multimeric cytoplasmic domain is poised to regulate the translocation of ESX substrates\" and \"EccC~3~ and EccE~3~ collaborate to buttress the cytoplasmic domains of EccD~3~ and form a stable regulatory bridge\".
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Author response

> Essential revisions:
>
> 1\) The authors fail to see any higher order oligomers, which have been previously reported in native (Houben et al., 2012, van Winden et al., 2016) and also plasmid expressed conditions (Famelis et al., 2019; Beckham et al., 2017). These publications have reported higher order oligomers in multiple mycobacterial species (M. bovis BCG, M. marinum and M. smegmatis) and from different type VII secretion systems (ESX-1, ESX-3 and ESX-5). Higher order multimerization has also been suggested/observed by the corresponding author in previously published work (Rosenberg et al., 2015) for the EccC ATPase.

We simply do not have definitive proof of the "physiological" multimeric state of the protein complex and so decided not to speculate extensively about this important issue in our first submission. Prior work, well characterized in the editor's review, and including our published work, has strongly suggested higher order structural and functional oligomerization. In particular, the requirement for a an "R-finger" mechanism for EccC ATPase activity -- a hallmark of multimer formation -- makes it clear that at some point in the secretion cycle, the ATPase 1 domains act as oligomers. In the structure we present in this manuscript the ATPase 1 domains, which have been presumed to be the active motor domains based on structural, biochemical and genetic data, would require a total of 65 Å of movement to come into an active position where the R-finger from one protomer is positioned to stimulate catalysis in the next subunit. The requirement for this extraordinarily large movement of the ATPase domains makes it difficult to presuppose the path of the ATPase domains during the secretion cycle. In our revision we comment on this issue in the Discussion and alter the model figure (revised Figure 6) to reflect the need for these molecular motions.

> Importantly, Beckham et al. and Famelis et al. showed that these higher order oligomers are only present in the void peak fraction of the SEC analysis. In the current study it is unfortunately not mentioned which SEC fractions were used for the cryo-EM analysis, but it is suspected that the void peak fractions were not analyzed. To confirm that the native ESX-3 complex forms higher order oligomers, the authors should more thoroughly investigate the presence of these multimers, e.g. by including the void peak fractions in the analysis and/or analyzing the ESX-3 membrane complex by BN-PAGE analysis before SEC (including crosslinking).

In order to address this important concern, we have repeated the purification and collected a new cryo-EM data set of of the "void" fractions. These micrographs contain a majority of aggregated particles and are challenging to analyze, which is why we left them out of the first submission. However, there is a small population of monodispersed particles, which we have analyzed. The majority of these particles appear to be in the dimer state we have described, however, additionally, we see a small set of side views that are consistent with a larger particle of approximately 280 Å and that look similar to particle described in Famelis et al. In terms of the size, these particles could be interpreted as a hexameric form, but given the excellent distribution of views we observe in the dimer form we were surprised not to observe any evidence in the 2D class averages that would suggest symmetry higher than 2. It is certainly possible that these particles do not represent a fixed state but rather misincorporation of several dimers into a single micelle. We present these data in a new supplemental figure (Figure 1---figure supplement 4).

We have also attempted to crosslink the purified protein before running on the SEC and we do not see evidence of additional, significant crosslinking between dimers, in the purified preparation. We include this gel in [Author response image 1](#respfig1){ref-type="fig"} but not in the resubmitted manuscript.

![](elife-52983-resp-fig1){#respfig1}

> 2\) The authors propose an alternative and contentious model for protein translocation through the membrane complex, i.e. through a hydrophobic cavity formed by two EccD subunits, which is (partially) filled with lipids. Indeed, the presence of such a large cavity in between these two subunits is striking. However, the surface of this cavity consists, except for a number of polar residues, solely of hydrophobic residues. In agreement with a hydrophobic interface, the structure reveals extra densities at the periplasmic part of the cavity suggesting the presence of lipids or detergent. The cytoplasmic half of the cavity does not reveal these extra densities, which could be caused by the presence of several polar residues here, as also discussed by the authors. However, lipids in this part of the cavity could have been removed during solubilization of the complex.

As the reviewers note, the presence of a large cavity in the inner membrane, formed by the EccD dimer, is very unusual. In searching the literature and doing extensive homology searches, we have discovered no clear examples of similar membrane protein structures. In our structure, the periplasmic side of the EccD cavity is completely filled with detergent or lipids carried over from the purification, which would provide a mechanism for the "hole" to be sealed. Although we do believe that this cavity will eventually be shown to be of functional importance, as the reviewers appear to recognize, to fully understand the native state and function of EccD is beyond the scope of the current work. We have thus rewritten the Results and Discussion section to be more descriptive and less speculative.

> To show that partially lipid-filled cavities have been observed also in other membrane complexes, the authors refer to a publication describing the presence of a similar lipid plug in the central cavity of a reconstituted rotor cylinder of the ATP synthase (Meiers et al. Febs Lett 2001). However, it is explicitly mentioned in this article that \"As the detergent-purified c cylinder is completely devoid of phospholipids, these are incorporated into the central hole from one side of the cylinder during the reconstitution procedure\". It therefore remains unclear whether such lipid-plugged membrane pores actually exists in vivo.

We have removed the reference to the c cylinder as we do not want to confuse the reader with a loose analogy that may not provide useful evidence.

> In addition, Poweleit et al. propose a \"lipid mediated\" mechanism of protein translocation through this hydrophobic pore. It is difficult to envision though how lipids would be able to mediate translocation of folded substrate dimers with mostly hydrophilic surfaces. This would be a completely new mechanism of protein translocation not seen for any other protein secretion machineries. In addition, the authors speculate even further that besides (hydrophilic) proteins also hydrophobic molecules, such as lipids, could be transported through this cavity, while there is no clear evidence that type VII secretion systems are able mediate lipid transport. In conclusion, while it is indeed striking that such a large cavity is present in the ESX-3 complex, the authors should more cautiously discuss this model, by also mentioning the major problems with this model as discussed above. The translocation model of substrates through the central pore of a hexameric complex is far less speculative, as it is supported by experimental data, published by several groups (as also mentioned in the Discussion). This model should therefore get more emphasis.

We have restructured and rewritten the Discussion to further emphasize the relationship between the prior literature and the oligomer model.

> 3\) The regulatory role of the \"cytoplasmic bridge\" is speculative and should be more carefully discussed. e.g. \"multimeric cytoplasmic domain is poised to regulate the translocation of ESX substrates\" and \"EccC~3~ and EccE~3~ collaborate to buttress the cytoplasmic domains of EccD~3~ and form a stable regulatory bridge\".

Our intension with this language was to point out the interactions between the cytoplasmic domain of EccD~3~ and the other two proteins with significant cytoplasmic domains, EccE~3~ and EccC~3~. EccD~3~ contains a highly conserved region (116-125) in the linker connecting the ubiquitin-like domain at the N-terminus to the transmembrane region. Despite the strong conservation, the interface made by this region each copy of EccD~3~ in the homodimer is strikingly different. In one case, the region interacts extensively with the other cytoplasmic domain of EccD~3~ as well as with EccE, anchoring EccE in a rigid conformation. In contrast, this region has a completely different conformation in the symmetry related copy of EccD, where it reaches in a different direction to form a nexus of interactions with EccB, and EccC. Given the need for the rearrangement of EccC to accommodate the R-finger mechanism of the ATPase 1 domain, we speculate that flexibility of the EccD~3~ linker could allow for the release of EccE and EccC from their rigid positions, thus allowing for a rearrangement of the ATPase domains into an active conformation. To respond to the comments. we have clarified this idea of a "regulatory bridge" and separated the observations of the structure from the speculation about the functional relevance, which is now in the Discussion. We have updated and expanded Figures 3C-D, Figure 4C-D and Figure 5C to highlight these interactions.
